Landmark Uptime Institute “Executive Advisory” Report Series is the Definitive Strategic and Practical Guide for Digital Infrastructure Sustainability
19.4.2022 13:02:00 EEST | Business Wire | Press release
Uptime Institute, the global digital infrastructure authority, today announced a new Executive Advisory report series titled “Digital infrastructure sustainability – a manager’s guide” and released the first installment: “Creating a sustainability strategy.” The new advisory series is a uniquely practical resource that owners and operators can use to establish and implement an effective sustainability strategy.
The launch of this comprehensive executive advisory series is the latest step in Uptime’s longstanding and expanding program to inform, guide and support sustainability efforts within the sector – and it comes at a critical time for digital infrastructure operators. Governments worldwide are beginning to establish new regulations and promulgate new policies to discourage unsustainable data center growth, drive procurement of low-carbon data center services, and move toward net-zero carbon emissions goals.
However, research by Uptime clearly shows that most organizations have not put in place many of the strategies, processes and controls they will need to meet all stakeholder expectations and legislator demands. According to Uptime’s 2021 Global Data Center Survey, most organizations tend to only compile and report on power-related sustainability metrics, while far too few are tracking other key elements such as water use (just 51%), greenhouse gas (GHG) emissions (just 33%), and IT efficiency (just 25%).
The first report in the series, “Creating a sustainability strategy,” defines the key elements to include in a sustainability strategy, the actions necessary for a successful implementation, and the processes required to measure progress against goals and objectives. Download an executive summary of the report and register for the accompanying webinar on Tuesday, May 10th at 9:00 a.m. PDT here.
The complete series of six reports takes managers through the key areas that must be addressed in an environmental sustainability strategy, ranging from creating the strategy, reducing energy consumption, buying renewable energy, tracking and reporting carbon emissions, managing water consumption, and equipment reuse and recycling. The advisory series also provides guidance on compliance with and the adoption of critical standards and legislative initiatives, many of which are both confused and confusing.
“As sustainability requirements become more demanding, digital infrastructure operators must be prepared with a comprehensive, actionable sustainability strategy,” said Andy Lawrence, founding member and executive director, Uptime Intelligence.
“This advisory series is a “how-to” guide to implementing effective environmental sustainability initiatives that span all facilities and IT operations and address the needs of all stakeholders inside and outside the organization,” said Jay Dietrich, research director of sustainability, Uptime Intelligence and lead author of the report series.
Uptime has been advising operators of digital infrastructure on sustainability and efficiency since 2007, the year of the first Uptime Institute Green Data Center forum. Through its Sustainability Consulting Services and related offerings, Uptime advises some of the world’s largest digital infrastructure owners and operators, many vendors and equipment manufacturers, regulators and policymakers to help the sector design, build and operate digital infrastructure sustainably—without compromising resiliency.
UPCOMING REPORTS IN THE SERIES:
- “Reducing the energy footprint” – The first objective of a sustainability plan is to minimize energy use through efficiency measures. Further benefits will be realized by replacing electricity from nonrenewable sources with renewably generated energy.
- “Tackling greenhouse gases” – Operators of digital infrastructure must have a greenhouse gas emissions reduction goal that takes into account Scope 1, 2 and 3 emissions — and they must report these reductions in accordance with agreed policy.
- “IT efficiency: the critical core of digital sustainability” – A digital sustainability strategy should incorporate both the facilities and IT operations, even for colocation operators. This report covers strategies, software tools and metrics that can help drive up IT efficiency.
- “Navigating regulations and standards” – Critical digital infrastructure is subject to an expanding set of regulations, directives and standards, with varying levels of maturity and acceptance. Most are voluntary, but more are becoming mandatory.
- “Three sustainability elements: water, the circular economy and siting” – This report discusses three important elements of the sustainability strategy: water use; siting, including design and certification; and reuse, disposal, and recycling. Addressing these elements can significantly reduce the environmental impact of digital infrastructure.
- “Glossary of digital infrastructure sustainability” – This document explains the key terms used by those defining, regulating, and applying digital infrastructure sustainability strategies.
UPCOMING DIGITAL INFRASTRUCTURE SUSTAINABILITY WEBINARS:
Uptime will be hosting a webinar series to deliver in-depth insights and to facilitate discussions following the release of each report. Scheduled for Tuesday, May 10th at 9:00 a.m. PDT, the first webinar will cover the “Creating a sustainability strategy” report. The second webinar will take place on Tuesday, June 7th at 9:00 a.m. PDT and explore both the “Tackling greenhouse gases” and “Reducing the energy footprint” reports. To view the webinar schedule and register to attend, click here .
Uptime Institute Network Members, the world’s largest group of data center owners and operators, will have exclusive access to the complete contents of each installment of the report series upon release, while non-members will have access to executive summary copies.
Download the executive summary of the first report and find out more about each subsequent report listed above here.
Learn more about Uptime Institute Network Membership and request a free guest trial here.
About Uptime Institute
Uptime Institute is the Global Digital Infrastructure Authority. Its Tier Standard is the IT industry’s most trusted and adopted global standard for the proper design, construction, and operation of data centers – the backbone of the digital economy. For over 25 years, the company has served as the standard for data center reliability, sustainability, and efficiency, providing customers assurance that their digital infrastructure can perform at a level that is consistent with their business needs across a wide array of operating conditions. With its data center Tier Standard & Certifications, Management & Operations reviews, broad range of related risk and performance assessments, and accredited educational curriculum completed by over 10,000 data center professionals, Uptime Institute has helped thousands of companies, in over 100 countries to optimize critical IT assets while managing costs, resources, and efficiency.
Uptime Institute is headquartered in New York, NY, with offices in Seattle, London, Sao Paulo, Dubai, Singapore, and Taipei and staff in over 25 other countries. For more information, please visit www.uptimeinstitute.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220419005362/en/
Contact information
Brenda South, Uptime Institute
bsouth@uptimeinstitute.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam
Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 12:18:00 EEST | Press release
Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
